Literature DB >> 8548400

Pharmacological inhibition of CD28-stimulated T cell activation.

D Wancio1, N K Damle, C C Bansbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548400     DOI: 10.1007/bf01778334

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

1.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

2.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

Authors:  P S Linsley; E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

Authors:  F J Dumont; M J Staruch; S L Koprak; M R Melino; N H Sigal
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

4.  Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation.

Authors:  D S Lingk; M A Chan; E W Gelfand
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

5.  Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells.

Authors:  G M Lewis; R G Caccese; R J Heaslip; C C Bansbach
Journal:  Agents Actions       Date:  1993

6.  T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.

Authors:  K V Prasad; Y C Cai; M Raab; B Duckworth; L Cantley; S E Shoelson; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.